Neolytica - A QPharma Company
Rick Johansen is an accomplished executive with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as Vice President of Sales at Neolytica, a QPharma subsidiary, Rick Johansen leverages advanced AI and Data Analytics technologies to enhance Medical Affairs and Commercial Sales. Previous roles include consultancy for emerging BioPharma companies, VP of Sales & Marketing at inPhronesis, and Director of Business Development at Indegene, where innovative commercial partnership models were developed. Rick Johansen also founded Veterans in Healthcare to support veteran professionals and held senior positions at Everyday Health Inc. and DoctorDirectory.com, focusing on strategic accounts and sales team development. A retired Commander from the US Navy, Rick Johansen's military service earned multiple commendations, including the Defense Meritorious Service Medal. Education includes a Bachelor's degree from State University of New York Maritime College and an MBA from Dowling College.
This person is not in any teams
Neolytica - A QPharma Company
A subsidiary of QPharma, Neolytica brings solutions and a portfolio of products that leverage cutting edge technologies like AI and Data Analytics to deliver significant value in strategic and operational aspects of Medical Affairs, Market Access, Commercial Marketing and Commercial Sales. Our offerings portfolio includes: Ti Expert : This technology and consulting solution brings comprehensive access to data about highly qualified and validated medical professionals, including professional spheres of influence, social relationships, and promotional activities. NotifyMe : A Healthcare KOL engagement service with email alerts. An application that enables enterprise-scale social listening and provides actionable alerts on healthcare stakeholders in a desired therapeutic area. Ti Risk : Dependence on Opioid has increased burden on patients, employers, insurers, society, and the health care system. Our product aims to address this by identifying prescribers and patients that are potentially involved in diversion of opioids by following patient journey and prescriber behaviour, along with supplementary secondary research – Real-time and At-risk scoring analysis. For more details, visit - www.neolytica.ai